Yahoo Finance

Frontier Medicines Announces Renowned Physician Scientist Piro Lito, M.D., Ph.D., Joins Scientific Advisory Board

SOUTH SAN FRANCISCO, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthrough therapies against ...
mskcc.org

MSK Researchers Are Learning Why Some Patients Develop Resistance to Targeted Lung Cancer Drug

MSK investigators studying resistance to targeted drugs like sotorasib: (front row, left to right) Yonina Murciano-Goroff and Jenny Xue, and (back row, left to right) Bob Li, Piro Lito, and Yulei Zhao ...
Medical Xpress

A potential advance against RAS-driven cancers—researchers find certain inhibitors can short-circuit mutation signals

Each year, more than 3 million people are diagnosed with cancers driven by mutations in three RAS-family genes: KRAS, NRAS, and HRAS. RAS-family mutations are associated with numerous types of cancer.
Mena FN

PAQ Therapeutics Appoints Andrew Krivoshik, MD, Phd, As Chief Medical Officer, Announces Addition Of Eric Rubin, MD, And Piro Lito MD, Phd, To Advisory Board

BURLINGTON, Mass., May 7, 2025 /PRNewswire/ -- PAQ Therapeutics, a biotechnology company developing best- and first-in-class KRAS degraders for lethal cancers lacking effective treatment options, ...
Healio

Association awards research fellowships

Please provide your email address to receive an email when new articles are posted on . The Association of American Cancer Institutes awarded translational cancer research fellowships to Olya Grove, ...
Yahoo Finance

PAQ Therapeutics Appoints Andrew Krivoshik, MD, PhD, as Chief Medical Officer, Announces Addition of Eric Rubin, MD, and Piro Lito MD, PhD, to Advisory Board

"We are excited to welcome Dr Andrew Krivoshik to the team, as he brings a wealth of experience in delivering much-needed oncology medicines to patients, in addition to a strong understanding of the ...